Nordicus Partners Corp: issues $147,000 promissory note

What happened Nordicus Partners Corp filed a Current Report on Form 8-K on Oct 21, 2026 reporting that on Oct 15, 2026 it issued to ABCHill Holding ApS (the “Lender”) a Promissory Note (the “Note”) in the principal amount of $147,000. The Note is payable on demand and bears interest at a rate equal to the lesser of 6.0% per annum and the maximum rate permitted by applicable law; interest is calculated on the basis of a 365-day year and actual days elapsed. The Lender is wholly owned and controlled by Christian Hill-Madsen, a Director of the Company’s subsidiaries Orocidin A/S and Bio-Convert A/S and CEO of NP Bioinnovation A/S and COO of NoviThera ApS.

Key details

• Principal amount: $147,000; Note issued Oct 15, 2026.
• Interest: lesser of 6.0% per annum and the maximum rate permitted by law; 365-day year, actual days elapsed.
• Repayment and remedies: payable on demand; Company may prepay at any time without premium or penalty; payments applied first to accrued interest then to principal; Lender may declare amounts immediately due and payable and pursue customary remedies on default.
• Other: Note was issued in reliance on the exemption in Section 4(a)(2) of the Securities Act and has not been registered.

Why it may matter The Form 8-K reports Item 1.01 (entry into a material definitive agreement) and Item 2.03 (creation of a direct financial obligation), documenting the issuance of a demand promissory note of $147,000 to an entity controlled by a subsidiary director. A filing does not show why the insider traded or why the company acted.